Axsome Therapeutics AXSM Debt Repayments
Debt Repayments at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's debt repayments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Axsome Therapeutics's debt repayments?
- Axsome Therapeutics (AXSM) reported debt repayments of $70M in Q1 2026.
- What does debt repayments mean?
- Cash used to pay down the principal amount of debt.
- How do you interpret debt repayments?
- An increase signals active debt reduction or the maturity of debt instruments, which reduces future interest burdens.
- How does debt repayments compare across companies?
- Varies significantly based on the company's capital structure and debt maturity schedule compared to industry peers.